Details of Drug

Details of Drug

 Drug General Information (ID: D1876)
  Drug Name
Ravulizumab
  Drug Type Monoclonal antibody
  Drug Synonymous
Ravulizumab [USAN]; UNII-C3VX249T6L; C3VX249T6L; ALXN1210
    Click to Show/Hide
  Disease Class 3A20-3A2Z: Haemolytic anemia
  Therapeutic Class Selective Immunosuppressants
  External Link
TTD ID D0NW7Y

Drug-Drug Interaction Network
  Sunburst Graph
AM007  Pharmacodynamic antagonistic effects
BM107  Attenuated pharmacological effects (Unspecific)
  Relation Graph
 Full list of drugs interacting with Ravulizumab
      Pharmacodynamic antagonistic effects
   Attenuated pharmacological effects (Unspecific) Drug Num:  3
Drug ID
 
Drug Name
 Formula Pubchem ID Severity Level Interaction Detail REF
D0764
 
Human immunoglobulin G (intramuscular)
 
NA
 
NA
Minor    Inter Info   
[1], [2], [3]
D0765
 
Human immunoglobulin G (intravenous)
 
NA
 
NA
Minor    Inter Info   
[1], [2], [3]
D0766
 
Human immunoglobulin G (subcutaneous)
 
NA
 
NA
Minor    Inter Info   
[1], [2], [3]
References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
3 Product Information. Ultomiris (ravulizumab). Alexion Pharmaceuticals Inc, Cheshire, CT.